We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

Scientists at The Institute of Cancer Research, London have found a way to identify people with inflammatory bowel disease (IBD) who are at the highest risk of developing bowel cancer. IBD includes ...

The goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma, three paediatric solid tumours in which high-risk patient ...

"Search" is our twice-yearly newsletter to supporters. In our 50th edition of the Autumn Search issue, we look at the latest research news featuring a new breast cancer drug approval in the UK, for ...

Our group's aim is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma. The goal of our laboratory is to improve the treatment and survival of ...

The Division of Breast Cancer Research, which incorporates the Breast Cancer Now Research Centre, contains more than 100 scientists and clinicians working in more than 20 different groups. To fulfil ...

Professor Kamil R Kranc graduated in medicine from the Medical University of Silesia (Poland) in 2000. He then moved to the University of Oxford to obtain a DPhil in Biochemistry in 2003, followed by ...

An innovative study has uncovered two genes that promote the formation of prostate tumours. Both genes activate a signalling pathway that plays a part in the growth, division and death of cells and is ...